BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20462658)

  • 21. Primary cutaneous marginal zone B-cell lymphoma with anetoderma: spontaneous involution plus de novo clonal expansion.
    Ferrara G; Cusano F; Robson A; Stefanato CM
    J Cutan Pathol; 2011 Apr; 38(4):342-5. PubMed ID: 21219395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
    Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M
    Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma.
    Gallardo F; Bellosillo B; Espinet B; Pujol RM; Estrach T; Servitje O; Romagosa V; Barranco C; Boluda S; García M; Solé F; Ariza A; Serrano S
    Hum Pathol; 2006 Jul; 37(7):867-73. PubMed ID: 16784987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent.
    Teckie S; Qi S; Lovie S; Navarrett S; Hsu M; Noy A; Portlock C; Yahalom J
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):130-7. PubMed ID: 25863760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relapsed or refractory nongastric marginal zone B-cell lymphoma: multicenter retrospective analysis of 92 cases.
    Oh SY; Kim WS; Kim SJ; Kim JS; Kim SH; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Kim JG; Yang DH; Kang HJ; Choi CW; Park J; Choi YJ; Kim HJ; Kwon JH; Suh C; Kim HJ
    Am J Hematol; 2009 Dec; 84(12):826-9. PubMed ID: 19890833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous lymphomas showing prominent granulomatous component: clinicopathological features in a series of 16 cases.
    Gallardo F; García-Muret MP; Servitje O; Estrach T; Bielsa I; Salar A; Abella E; Barranco C; Pujol RM
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):639-47. PubMed ID: 19207677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
    Senff NJ; Willemze R
    Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
    Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
    Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background.
    Geyer JT; Ferry JA; Longtine JA; Flotte TJ; Harris NL; Zukerberg LR
    Am J Clin Pathol; 2010 Jan; 133(1):59-69. PubMed ID: 20023259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphoma of the ocular adnexa: A study of 353 cases.
    Ferry JA; Fung CY; Zukerberg L; Lucarelli MJ; Hasserjian RP; Preffer FI; Harris NL
    Am J Surg Pathol; 2007 Feb; 31(2):170-84. PubMed ID: 17255761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
    Zinzani PL; Quaglino P; Pimpinelli N; Berti E; Baliva G; Rupoli S; Martelli M; Alaibac M; Borroni G; Chimenti S; Alterini R; Alinari L; Fierro MT; Cappello N; Pileri A; Soligo D; Paulli M; Pileri S; Santucci M; Bernengo MG;
    J Clin Oncol; 2006 Mar; 24(9):1376-82. PubMed ID: 16492713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy.
    Wenzel C; Fiebiger W; Dieckmann K; Formanek M; Chott A; Raderer M
    Cancer; 2003 May; 97(9):2236-41. PubMed ID: 12712477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma.
    Oh SY; Ryoo BY; Kim WS; Kim K; Lee J; Kim HJ; Kwon JM; Lee HR; Ko YH; Oh SJ; Park KW; Kim HJ; Kwon HC; Nam E; Kim JH; Park YH; Lee SS; Kim HY; Park K
    Ann Hematol; 2006 Nov; 85(11):781-6. PubMed ID: 16847665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nongastric marginal zone B-cell lymphoma: a prognostic model from a retrospective multicenter study.
    Oh SY; Kwon HC; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Bang SM; Kim JH; Park J; Ryoo BY; Lee SS; Kim HY; Park K; Kim HJ
    Cancer Lett; 2007 Dec; 258(1):90-7. PubMed ID: 17936499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab.
    Kyrtsonis MC; Siakantaris MP; Kalpadakis C; Dimopoulou MN; Vassilakopoulos TP; Kontopidou FN; Antoniou C; Korkolopoulou P; Panayiotidis P; Pangalis GA
    Eur J Haematol; 2006 Oct; 77(4):300-3. PubMed ID: 16856917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic, immunophenotypic, and molecular characterization of primary cutaneous follicular B-cell lymphoma.
    Bergman R; Kurtin PJ; Gibson LE; Hull PR; Kimlinger TK; Schroeter AL
    Arch Dermatol; 2001 Apr; 137(4):432-9. PubMed ID: 11295923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anetodermic primary cutaneous B-cell lymphoma: a unique clinicopathological presentation of lymphoma possibly associated with antiphospholipid antibodies.
    Hodak E; Feuerman H; Barzilai A; David M; Cerroni L; Feinmesser M
    Arch Dermatol; 2010 Feb; 146(2):175-82. PubMed ID: 20157029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases.
    Demirci H; Shields CL; Karatza EC; Shields JA
    Ophthalmology; 2008 Sep; 115(9):1626-31, 1631.e1-3. PubMed ID: 18440641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cutaneous blastic marginal zone lymphoma: A comprehensive clinical, light microscopic, phenotypic and cytogenetic appraisal.
    Magro CM; Kalomeris T; Roberts A
    Ann Diagn Pathol; 2023 Apr; 63():152101. PubMed ID: 36634549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary cutaneous marginal zone B-cell lymphoma: clinical and histological aspects.
    Khaled A; Sassi S; Fazaa B; Ben Hassouna J; Ben Romdhane K; Kamoun MR
    Pathologica; 2009 Feb; 101(1):18-20. PubMed ID: 19771768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.